Anúncio
Anúncio
AVIR
Atea Pharmaceuticals, Inc. Common Stock
3.46
USDPatrocinado
-0.15
-4.24%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
3.46
0.00
+0.09%
Relatórios de Lucros AVIR
Rácio de surpresa positiva
AVIR separação 15 de 21 últimas estimativas.
71%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.54
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+1.89%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+35.00%
Atea Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 12 de nov. de 2025, AVIR reported earnings of -0.53 USD per share (EPS) for Q3 25, missing the estimate of -0.44 USD, resulting in a -18.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an aumentar of 1.89% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Atea Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Atea Pharmaceuticals, Inc. Common Stock reported EPS of -$0.53, missing estimates by -18.09%, and revenue of $0.00, 0% as expectations.
How did the market react to Atea Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -12.57%, changed from $3.50 before the earnings release to $3.06 the day after.
When is Atea Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for Atea Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 4
analistas, Atea Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio